Shelton Capital Management Conmed Corp Transaction History

Shelton Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$102.55 - $136.38 $171,771 - $228,436	1,675 New	1,675 $227,000
Q2 2022 Aug 11, 2022	SELL	$88.23 - $154.18 $165,078 - $288,470	-1,871 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$128.08 - $145.09 $6,404 - $7,254	-50 Reduced 2.6%	1,871 $257,000
Q4 2020 Feb 16, 2021	BUY	$77.7 - $112.82 $149,261 - $216,727	1,921 New	1,921 $215,000
Q1 2020 May 13, 2020	SELL	$39.81 - $112.01 $96,857 - $272,520	-2,433 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$83.97 - $102.19 $15,618 - $19,007	-186 Reduced 7.1%	2,433 $234,000
Q2 2019 Aug 14, 2019	BUY	$78.27 - $86.94 $187,926 - $208,742	2,401 Added 1101.38%	2,619 $224,000
Q1 2019 May 10, 2019	BUY	$60.79 - $83.18 $13,252 - $18,133	218 New	218 $2.62 Million

299

36M

119K

5.1K

Ticker CNMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 30,482,400
Market Cap $1.89B
Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.